Spot Urine-guided Salt Reduction in Chronic Kidney Disease Patients
- PMID: 28579314
- DOI: 10.1053/j.jrn.2017.04.005
Spot Urine-guided Salt Reduction in Chronic Kidney Disease Patients
Abstract
Objective: Dietary salt restriction is important in patients with chronic kidney disease (CKD) to reduce hypertension, cardiovascular events, progression of CKD, and mortality. However, recommending salt reduction for patients is difficult without knowing their actual sodium intake. This study evaluated the effectiveness of spot urine-guided salt reduction in CKD outpatients.
Design: A prospective cohort study was used.
Subjects: This study included a total of 127 adult outpatients (aged 60 ± 18 years, 80 males) with CKD. Their baseline estimated glomerular filtration rate was 51.4 ± 25.1 (mL/minute/1.73 m2), and 64 (50%) of them were with CKD stage 3a or 3b (both 32 [25%]).
Intervention: We informed the patients of their individual spot urine-estimated salt intake every time they visited the outpatient clinic. Based on the data, the nephrologist encouraged the patients to achieve their salt restriction goal.
Main outcome measure: The primary outcome was the estimated salt excretion, and the secondary outcome was the urinary protein-to-Cr ratio (UPCR). Multiple regression analyses were performed to clarify the contributing factors of changes in both outcomes.
Results: Over a follow-up of 12 months, the median number of patients' visits was 7 (5-8). The estimated salt intake was significantly reduced from 7.98 ± 2.49 g/day to 6.77 ± 1.77 g/day (P < .0001). The median UPCR was also reduced from 0.20 (0.10-0.80) to 0.10 (0.10-0.48) (P < .0001). On multiple regression analysis, a reduction in UPCR was positively associated with the baseline UPCR and a reduction in systolic blood pressure significantly (P < .0001 and P < .01, respectively) as well as positively correlated with a reduction in the estimated salt intake, with borderline significance (P = .08).
Conclusions: Providing spot urine-estimated salt intake feedback effectively motivated CKD patients to reduce their salt intake. Spot urine-guided salt reduction may slow CKD progression through decreased urinary protein excretion.
Copyright © 2017 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Spot urine sodium measurements do not accurately estimate dietary sodium intake in chronic kidney disease.Am J Clin Nutr. 2016 Aug;104(2):298-305. doi: 10.3945/ajcn.115.127423. Epub 2016 Jun 29. Am J Clin Nutr. 2016. PMID: 27357090 Free PMC article. Clinical Trial.
-
Spot urine-guided salt reduction is effective in Japanese cardiology outpatients.Hypertens Res. 2012 Nov;35(11):1069-71. doi: 10.1038/hr.2012.98. Epub 2012 Jul 5. Hypertens Res. 2012. PMID: 22763481
-
Measured sodium excretion is associated with CKD progression: results from the KNOW-CKD study.Nephrol Dial Transplant. 2021 Feb 20;36(3):512-519. doi: 10.1093/ndt/gfaa107. Nephrol Dial Transplant. 2021. PMID: 32582942
-
Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.Adv Exp Med Biol. 2017;956:61-84. doi: 10.1007/5584_2016_147. Adv Exp Med Biol. 2017. PMID: 27757935 Review.
-
Dietary salt intake in chronic kidney disease: recent studies and their practical implications.Pol Arch Intern Med. 2024 May 28;134(5):16715. doi: 10.20452/pamw.16715. Epub 2024 Mar 28. Pol Arch Intern Med. 2024. PMID: 38546269 Review.
Cited by
-
Dietary Sodium Intake and Health Indicators: A Systematic Review of Published Literature between January 2015 and December 2019.Adv Nutr. 2020 Sep 1;11(5):1174-1200. doi: 10.1093/advances/nmaa049. Adv Nutr. 2020. PMID: 32449929 Free PMC article.
-
Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD.Kidney Int Rep. 2020 Jun 2;5(8):1240-1250. doi: 10.1016/j.ekir.2020.05.025. eCollection 2020 Aug. Kidney Int Rep. 2020. PMID: 32775823 Free PMC article.
-
The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial.Sci Rep. 2021 Sep 3;11(1):17666. doi: 10.1038/s41598-021-97113-w. Sci Rep. 2021. PMID: 34480075 Free PMC article. Clinical Trial.
-
Paucity of high-quality studies reporting on salt and health outcomes from the science of salt: A regularly updated systematic review of salt and health outcomes (April 2017 to March 2018).J Clin Hypertens (Greenwich). 2019 Feb;21(2):307-323. doi: 10.1111/jch.13450. Epub 2018 Dec 27. J Clin Hypertens (Greenwich). 2019. PMID: 30589204 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical